Demaceo Howard, M.D.
NPI 1225006752 · Pain Medicine (Anesthesiology) Physician · Dallas, TX
Enrolled with Medicare as Practitioner - Interventional Pain Management · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1225006752
- Entity type
- Individual
- Primary specialty
- Pain Medicine (Anesthesiology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- S2344 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
899 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 306 | $121 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 242 | $85 |
| Testing for Presence of Drug, By Chemistry Analyzers80307 | 111 | $61 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0482 | 50 | $195 |
| Destruction of Lower Or Sacral Spinal Facet Joint Nerves Using Imaging Guidance, Single Facet Joint64635 | 32 | $188 |
| Destruction of Lower Or Sacral Spinal Facet Joint Nerves Using Imaging Guidance, Each Additional Facet Joint |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 33 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 901 | 120 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 235 | 35 |
| Gabapentin | 191 | 45 |
| Tizanidine Hcl | 182 | 45 |
| Cyclobenzaprine Hcl | 155 | 35 |
| Pregabalin | 131 | 27 |
| Methocarbamol | 104 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,640 across 53 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-10
- Last updated
- 2019-07-18
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.